Literature DB >> 12031922

Diagnostic value of procalcitonin serum levels in comparison with C-reactive protein in allogeneic stem cell transplantation.

Lothar Hambach1, Matthias Eder, Elke Dammann, Andreas Schrauder, Karl-Walter Sykora, Christian Dieterich, Philip Kirschner, Jürgen Novotny, Arnold Ganser, Bernd Hertenstein.   

Abstract

BACKGROUND AND OBJECTIVES: Infections represent the major complications following allogeneic stem cell transplantation (SCT). A promising marker for a more specific and early detection of bacterial or fungal infections is procalcitonin (PCT). DESIGN AND METHODS: Maximum values (m) and increase (Delta) of PCT and C-reactive protein (CRP) were prospectively analyzed during 214 clinical events in a cohort of 61 patients undergoing allogeneic SCT. Systemic reactions during bacterial or fungal infections were classified according to the ACCP/SCCM criteria.
RESULTS: mPCT and mCRP (normal <0.5 microg/L and <5 mg/L, respectively) levels were high during bacterial and fungal infections (median 2.3 microg/L and 188 mg/L), moderately elevated during fever of unknown origin (median 1.5 microg/L and 82 mg/L) and low during clinical events for which there was no evidence of bacterial or fungal infections (median 0.4 microg/L and 55 mg/L). The area under the receiver operator characteristic (ROC) curve was 0.70 for mPCT, 0.76 for mCRP, 0.76 for DeltaPCT and 0.83 for DeltaCRP. Cut-off concentrations for optimum prediction of bacterial or fungal infection were: mPCT > 1 microg/L, mCRP > 100 mg/L, DeltaPCT > 1 microg/L and DeltaCRP > 50 mg/L. An increase of PCT during a bacterial or fungal infection was usually detected 1 day after the onset of fever, while the rise of CRP occurred 1 day before. mPCT was strongly correlated with the severity of systemic reaction during infection (sepsis vs severe sepsis/septic shock: p=0.0002). INTERPRETATION AND
CONCLUSIONS: The diagnostic value of PCT was not superior to that of CRP in the detection of bacterial or fungal infections after allogeneic SCT. However, PCT assays may be useful in studies which compare the severity of infectious complications.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12031922

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  24 in total

1.  A new prognostic model for chemotherapy-induced febrile neutropenia.

Authors:  Shin Ahn; Yoon-Seon Lee; Jae-Lyun Lee; Kyung Soo Lim; Sung-Cheol Yoon
Journal:  Int J Clin Oncol       Date:  2015-06-07       Impact factor: 3.402

2.  Change of procalcitonin predicts clinical outcome of febrile episodes in patients with hematological malignancies.

Authors:  M von Lilienfeld-Toal; A Schneider; K Orlopp; C Hahn-Ast; A Glasmacher; F Stüber
Journal:  Support Care Cancer       Date:  2006-05-30       Impact factor: 3.603

3.  Prediction of infectious complications by the combination of plasma procalcitonin level and localized infection before allogeneic hematopoietic cell transplantation.

Authors:  M Sato; H Nakasone; K Terasako-Saito; K Sakamoto; R Yamazaki; Y Tanaka; Y Akahoshi; H Nakano; T Ugai; H Wada; R Yamasaki; Y Ishihara; K Kawamura; M Ashizawa; S-i Kimura; M Kikuchi; A Tanihara; J Kanda; S Kako; J Nishida; Y Kanda
Journal:  Bone Marrow Transplant       Date:  2014-01-13       Impact factor: 5.483

4.  Procalcitonin--a marker of invasive fungal infection?

Authors:  H J Dornbusch; V Strenger; R Kerbl; H Lackner; W Schwinger; P Sovinz; C Urban
Journal:  Support Care Cancer       Date:  2005-01-19       Impact factor: 3.603

5.  Factors associated with positive blood cultures in outpatients with suspected bacteremia.

Authors:  K Wildi; S Tschudin-Sutter; S Dell-Kuster; R Frei; H C Bucher; R Nüesch
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-20       Impact factor: 3.267

6.  Substantially elevated C-reactive protein (CRP), together with low levels of procalcitonin (PCT), contributes to diagnosis of fungal infection in immunocompromised patients.

Authors:  Markéta Marková; Helena Brodská; Karin Malíčková; Veronika Válková; Petr Cetkovský; Michal Kolář; Martin Haluzík
Journal:  Support Care Cancer       Date:  2013-05-28       Impact factor: 3.603

7.  Infectious background of febrile advanced lung cancer patients who received chemotherapy.

Authors:  Katsuhiro Masago; Akiko Fukuhara; Yutaka Ito; Yukimasa Hatachi; Kaoru Irisa; Yuichi Sakamori; Yosuke Togashi; Shiro Fujita; Young Hak Kim; Tadashi Mio; Michiaki Mishima
Journal:  Oncol Lett       Date:  2010-09-01       Impact factor: 2.967

8.  Procalcitonin as a predictive marker of infections in chemoinduced neutropenia.

Authors:  Luisa Carnino; Silvia Betteto; Maria Loiacono; Annalisa Chiappella; Alice Giacobino; Libero Ciuffreda; Patrizia Lista; Giulio Mengozzi
Journal:  J Cancer Res Clin Oncol       Date:  2009-10-30       Impact factor: 4.553

9.  C-reactive protein used as an early indicator of infection in patients with systemic inflammatory response syndrome.

Authors:  Rafael Sierra; Jordi Rello; María Angeles Bailén; Encarnación Benítez; Antonio Gordillo; Cristobal León; Sebastián Pedraza
Journal:  Intensive Care Med       Date:  2004-09-11       Impact factor: 17.440

10.  A set of recombinant antigens from Echinococcus granulosus with potential for use in the immunodiagnosis of human cystic hydatid disease.

Authors:  V G Virginio; A Hernández; M B Rott; K M Monteiro; A F Zandonai; A Nieto; A Zaha; H B Ferreira
Journal:  Clin Exp Immunol       Date:  2003-05       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.